Friday, October 7th, 2011 at
Are you unable to fall asleep? Do you wake up often throughout the night? Do you feel well-rested when you awake in the morning? Do you want to improve your quality and quantity of your sleep? Symptoms of forgetfulness, headaches, lack of focus, itching, moodiness, cravings, headaches, and neck and backaches often disappear with a good night’s sleep.
Restful sleep is a must for health, vitality, longevity and fat loss. Researchers found that sleeping four hours a night interferes with your ability to secrete and regulate hormones, which in turn promote aging, increase appetite, add inches to your waistline and increases your risk of developing diabetes. Lack of sleep promotes an environment prime for inflammation and catabolism (muscle loss).
One loses “one IQ point” for every hour of lost sleep one didn’t get the night before. Cognitive and mood problems develop, along with an increased risk of high blood pressure and heart disease are just a few consequences of too little sleep. Read the rest of this entry
Thursday, October 6th, 2011 at
Dr. Brock Rondeau of Dr. Rondeau and Associates, a general dentist with a focus on orthodontics in London, is offering patients ways to sleep better at night time with sleep apnea treatments. Sleep apnea is a type of breathing disorder which is a serious, and potentially life-threatening condition characterized by brief interruptions of breathing during sleep.
“People who snore loudly are often the target of bad jokes and middle of the night elbow thrusts, but snoring is no laughing matter. While loud, disruptive snoring may strain relationships, it may signal a potentially life threatening disorder: obstructive sleep apnea. I am pleased to offer my patients a safe alternative for treating sleep apnea and allowing them to rest easy at night,” said Dr. Brock Rondeau, general dentist with a focus on London orthodontics.
The signs and symptoms of OSA include snoring, excessive daytime sleepiness, gasping or choking during the night, non-refreshed sleep, fragmented sleep, clouded memory, irritability, personality changes and morning headaches. Read the rest of this entry
Wednesday, October 5th, 2011 at
Home sleep testing is becoming increasingly popular as a method of diagnosing sleep apnea.
The home sleep test is a technological breakthrough in sleep apnea testing. It allows patients to get tested for sleep apnea in the comfort of their own home instead of paying a visit to a costly sleep lab.
One of the main advantages of home sleep testing is convenience. An overnight stay at a sleep lab can be uncomfortable and inconvenient. It can also and can influence a person’s sleep behavior. That means that the home sleep test can actually be a better representation of a person’s normal, natural sleep habits, leading to more accurate diagnosis. Read the rest of this entry
Tuesday, October 4th, 2011 at
Reportlinker.com announced the release of a new market research report “Global Sleep Apnea Diagnostic And Therapeutic Devices Industry“. This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others include Screening Devices), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces ,Masks and Humidifiers).
The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. Read the rest of this entry
Sunday, September 25th, 2011 at
Obstructive sleep apnea (OSA) is a common yet underdiagnosed condition. The aim of our study is to test whether prediabetes and type 2 diabetes are associated with obstructive sleep apnea (OSA) in extremely obese (BMI [greater than or equal to] 40 kg/m2) subjects.
One hundred and thirty seven consecutive extremely obese patients (99 females) from a controlled clinical trial [MOBIL-study (Morbid Obesity treatment, Bariatric surgery versus Intensive Lifestyle intervention Study) (ClinicalTrials.gov number NCT00273104)] underwent somnography with Embletta(R) and a 2-hour oral glucose tolerance test (OGTT). Read the rest of this entry
Saturday, September 24th, 2011 at
With its 2011 Sleep Apnea & Multi-Modal Transportation Conference (SAMTC) on November 8 – 9, 2011, the American Sleep Apnea Association (ASAA) continues its efforts to address a major cause of fatigue in US transportation. Co-sponsored by the Federal Motor Carrier Safety Administration (FMCSA) and the Federal Railroad Administration (FRA), this second in a series of health and safety conferences focuses on the role of obstructive sleep apnea (OSA) management within the major modes of transportation, including air, rail, ground and maritime. Read the rest of this entry
Saturday, September 24th, 2011 at
Harry Cutler, a sleep apnea patient, was under-employed and had no insurance when his obstructive sleep apnea became acute. “I was falling asleep at the wheel in the middle of the day” said Cutler. “I would wake up when my car bounced off of the opposite curb. After the fourth of fifth time, I decided that I needed to do something before I hurt myself, or someone else.”
Obstructive sleep apnea occurs when the soft palate at the back of the oral cavity relaxes during sleep, drapes down, closes against the rear of the tongue and causes a blockage of the airway. The patient often kicks and struggles for a breath and the wakes up gasping for air, only to fall back to sleep again and have the cycle continue. The draping of the soft palate into the airway also causes snoring as it vibrates when air rushes past it. It is estimated that 12%-25% of the population suffer from obstructive sleep apnea and the vast majority are untreated. This condition can lead to a host of health problems including hypertension, heart attack, stroke, depression, diabetes, and impotency, among others. Read the rest of this entry
Wednesday, September 21st, 2011 at
Sleep Group Solutions (SGS) a leader in dental continuing education takes pride in offering dentists top level courses on dental sleep medicine. With an increase in sleep apnea research and studies, Sleep Group Solutions plans to double courses offered to dentists interested in screening and treating sleep apnea in 2012.
Recent studies from the Journal of the American Medical Association prove sleep apnea linking to dementia in women. Breathing disorders, such as sleep apnea are getting more attention and research in the medical field, and now the dental field has perked an interest. Dentists are filling class rooms across the US to gain dental continuing education on how to screen and treat sleep apnea in house, through oral appliance therapy. Sleep Group Solutions continues to provide dentists with the education needed to treat OSA. ” In 2011 we offered the dental community 50 courses to choose from. With such an increased demand from the dental community, we are planning to offer around 70 for 2012,” John Nadeau, VP Sleep Group Solutions. Read the rest of this entry
Wednesday, September 21st, 2011 at
Advocate Condell Medical Center, along with the Alert, Well, And Keeping Energetic support group (A.W.A.K.E.), is hosting a CPAP vendor fair on Tuesday, Oct. 4, from 6:30 to 8:30 p.m., in the conference center at 801 South Milwaukee Ave. in Libertyville. The event is free and open to the public.
Sleep apnea patients, family members and physicians are invited to learn about new continuous positive airway pressure (CPAP) equipment, masks, and other items for clients. Vendors include; DeVilbiss, Phillips Respironics, ResMed, Candance, Fisher & Paykel along with Dr. Debbie Kline, an oral appliance specialist. Additionally, Advocate Home Health Care will offer free CPAP equipment pressure checks. Read the rest of this entry
Monday, September 19th, 2011 at
SleepApneaDisorder/ [Press release ]/ DETROIT /– Detroit Medical Center has been selected as the first Detroit area hospital to participate in a pivotal clinical study to evaluate the safety and effectiveness of a new therapy for patients with moderate to severe obstructive sleep apnea (OSA). The STAR trial (Stimulation Therapy for Apnea Reduction) will be conducted at leading medical centers across the United States and Europe, and will evaluate the efficacy of Inspire™ Upper Airway Stimulation (UAS) therapy, an implantable therapy that works with the body’s natural physiology to prevent airway obstruction during sleep. More than 18 million Americans suffer from OSA, which is characterized by repeated episodes of upper airway collapse during sleep. Patients with OSA stop breathing frequently during sleep, often for a minute or longer. Daytime sleepiness, depression, weight gain, increase in industrial accidents and diminished quality of life are all commonly observed in people who suffer from OSA as a result of fragmented sleep patterns. Furthermore, OSA is associated with the development of systemic hypertension, cardiovascular diseases (heart failure, heart rhythm disorders), stroke, and diabetes. Read the rest of this entry